New Delhi: Novo Nordisk is preparing to introduce its blockbuster diabetes drug Ozempic to the Indian market, with the launch expected within the next few weeks, according to people familiar with the company’s plans, Reuters claimed. The Danish pharmaceutical giant has been steadily expanding its presence in India, and the arrival of Ozempic marks a significant move in a country grappling with fast-rising rates of type 2 diabetes and obesity.

India now has the world’s second-largest population of diabetes patients, trailing only China. With obesity also climbing sharply, the market for weight-management medication is expanding at a rapid pace. Analysts believe the global weight-loss drug sector could reach $150 billion a year by the end of the decade, and manufacturers are racing to secu

See Full Page